Bigelow Investment Advisors LLC Acquires 1,722 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Bigelow Investment Advisors LLC lifted its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 73.9% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,053 shares of the financial services provider’s stock after buying an additional 1,722 shares during the quarter. Bigelow Investment Advisors LLC’s holdings in iShares Biotechnology ETF were worth $551,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Calamos Advisors LLC acquired a new position in iShares Biotechnology ETF during the 4th quarter worth $7,648,000. Oakworth Capital Inc. bought a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth $408,000. Tyche Wealth Partners LLC acquired a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at $802,000. Imprint Wealth LLC bought a new position in iShares Biotechnology ETF in the fourth quarter valued at about $202,000. Finally, SFI Advisors LLC bought a new position in iShares Biotechnology ETF in the fourth quarter valued at about $564,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB traded up $0.08 on Friday, hitting $124.72. 1,996,612 shares of the stock were exchanged, compared to its average volume of 1,809,704. iShares Biotechnology ETF has a 52 week low of $111.83 and a 52 week high of $141.16. The company’s 50-day moving average price is $135.29 and its 200 day moving average price is $129.51.

iShares Biotechnology ETF Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were issued a $0.126 dividend. The ex-dividend date was Thursday, March 21st. This represents a $0.50 annualized dividend and a yield of 0.40%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.